CA2727477C - Formulation injectable de paracetamol, stable et prete a l'emploi - Google Patents

Formulation injectable de paracetamol, stable et prete a l'emploi Download PDF

Info

Publication number
CA2727477C
CA2727477C CA2727477A CA2727477A CA2727477C CA 2727477 C CA2727477 C CA 2727477C CA 2727477 A CA2727477 A CA 2727477A CA 2727477 A CA2727477 A CA 2727477A CA 2727477 C CA2727477 C CA 2727477C
Authority
CA
Canada
Prior art keywords
solution
paracetamol
edta
stable
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2727477A
Other languages
English (en)
Other versions
CA2727477A1 (fr
Inventor
Ioulia Tseti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNI-PHARMA KLEON TSETIS
Original Assignee
UNI-PHARMA KLEON TSETIS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNI-PHARMA KLEON TSETIS filed Critical UNI-PHARMA KLEON TSETIS
Priority to CA2727477A priority Critical patent/CA2727477C/fr
Publication of CA2727477A1 publication Critical patent/CA2727477A1/fr
Application granted granted Critical
Publication of CA2727477C publication Critical patent/CA2727477C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Linvention a trait à une solution aqueuse de paracétamol stable administrable par perfusion intraveineuse qui comprend pour le paracétamol en solution au moins un composé de stabilisation-dissolution pris dans le groupe composé de cyclodextrines hydroxyalkyliques, et au moins un composé de stabilisation, de lEDTA ou du monothioglycérol, seul ou en combinaison, dans une concentration entre 0,001 % et 20 % m/v.
CA2727477A 2011-01-11 2011-01-11 Formulation injectable de paracetamol, stable et prete a l'emploi Expired - Fee Related CA2727477C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2727477A CA2727477C (fr) 2011-01-11 2011-01-11 Formulation injectable de paracetamol, stable et prete a l'emploi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2727477A CA2727477C (fr) 2011-01-11 2011-01-11 Formulation injectable de paracetamol, stable et prete a l'emploi

Publications (2)

Publication Number Publication Date
CA2727477A1 CA2727477A1 (fr) 2012-07-11
CA2727477C true CA2727477C (fr) 2017-11-21

Family

ID=46491859

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2727477A Expired - Fee Related CA2727477C (fr) 2011-01-11 2011-01-11 Formulation injectable de paracetamol, stable et prete a l'emploi

Country Status (1)

Country Link
CA (1) CA2727477C (fr)

Also Published As

Publication number Publication date
CA2727477A1 (fr) 2012-07-11

Similar Documents

Publication Publication Date Title
CA2799666C (fr) Preparation de paracetamol injectable stable, prete a l'emploi
US20120142779A1 (en) Stable injectable compositions
JP2017522382A (ja) パラセタモール及びイブプロフェンを含む水性配合物
DK2277546T3 (en) Stable, ready to use, injectable paracetamol formulation
CA3117511A1 (fr) Formulation a base de cyclodextrine d'un inhibiteur de bcl-2
KR101924786B1 (ko) 이부프로펜의 주사용 약제학적 조성물
CA2727477C (fr) Formulation injectable de paracetamol, stable et prete a l'emploi
US20120190750A1 (en) Stable ready to use injectable paracetamol formulation
AU2011200289B2 (en) Stable ready to use injectable paracetamol formulation
OA16245A (en) Stable ready to use injectable paracetamol formulation.
CN102600068A (zh) 稳定即用的可注射扑热息痛制剂
BR102014005885B1 (pt) Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
AU2011221386B2 (en) Stable injectable diclofenac compositions
EP3222271A1 (fr) Composition pharmaceutique stable comprenant du pemetrexed ou un sel pharmaceutiquement acceptable de celui-ci

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160107

MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20200113